Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Axitinib

EU orphan designation number: EU/3/10/844
Active ingredient: Axitinib
Indication: Treatment of renal cell carcinoma
Sponsor: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Centralised Orphan - Designation EMA/OD/119/10 (2011)1310 of 23/02/2011
25/07/2012 Centralised Orphan - Removal of orphan designation from Community Register